Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00535678 · ClinicalTrials.gov registry record

Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram

A clinical trial, sponsored by GE Healthcare.

Completed
Registry status
400
Enrollment target

NCT00535678: Completed study, sponsored by GE Healthcare.

NCT00535678 is a clinical trial that has completed, run by GE Healthcare. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00535678 has completed, sponsored by GE Healthcare.

COMPLETED
Registry status
400 participants
Enrollment target

Study Summary

To compare DBT and FFDM for screening effectiveness in women who present for screening mammography with respect to screening recall rate.

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2007-06
Est. Completion 2009-07
GE Healthcare

99 total trials

What the finished NCT00535678 record still lists

NCT00535678 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00535678 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00535678 about?

NCT00535678 is a clinical study titled "Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram". To compare DBT and FFDM for screening effectiveness in women who present for screening mammography with respect to screening recall rate.

What is the current status of trial NCT00535678?

This trial is currently completed. The enrollment target is 400 participants. The study started on 2007-06. Estimated completion is 2009-07.

Who is sponsoring clinical trial NCT00535678?

This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00535678, the US trial registry maintained by the National Library of Medicine. NCT00535678 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.